✳flâneur — a map of the web's best reading

PopVax: broadly-protective vaccines to prevent the next pandemic

popvax.com · 1,149 words · saved by 1 readers

PopVax is an Indian biotechnology company based in Hyderabad which is building a novel second-generation mRNA platform for low-cost broadly-protective vaccines via computationally-driven antigen design, starting with an open-source booster vaccine candidate that is intended to protect against the entire sarbecovirus species and, if things go well, the betacoronavirus genus, including current and future strains of SARS-CoV-2, the virus which causes COVID-19. We believe that making vaccines that can protect against entire families of high-risk pathogens today is our best shot at preventing future pandemics, while at the same time blunting the many long-term harms of seemingly innocuous infections that have begun to come to light, one example of which is the emerging consensus that multiple sclerosis (MS) is caused by the Epstein–Barr virus (EBV), which a large majority of adults have at some point been infected with. PopVax was founded by Soham Sankaran, and our research work has been fu

PopVax develops RNA vaccines and cancer immunotherapies to save 1 million lives each year PopVax is an Indian full-stack biotechnology company fighting infectious disease and cancer using machine learning-driven design and relentless empiricism. We are developing first-in-the-world and best-in-class vaccines against infectious diseases like Hepatitis C, Strep A, TB, influenza, HPV, malaria, and COVID-19, as well as precision cancer immunotherapies against hard-to-treat solid tumours like liver cancer and pancreatic cancer. PopVax's north star is our goal of developing novel vaccines and therap

Explore this link on the map →

related reading